​

​

美國

證券交易委員會

華盛頓特區20549

​

表格6-K

​

外國私人發行人之報告

根據13a-16或15d-16規則

根據1934年證券交易所法

​

對於九月份， 2024

​

登記編號001-39809

​

MEDIROm Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:☒ 20-F表格 ◻ 40-F表格

(註冊人名稱之英文翻譯)

​

2-3-1 Daiba, Minato-ku

Tokyo 135-0091, 日本

(總部辦公地址)

​

請勾選是否申報或將以20-F表格或40-F表格為封面申報年度報告：

☒ 20-F表☐ 40-F表單

​

​

​

INFORMATION CONTAINED IN THIS FORM 6-K REPORT

​

Issuance of Press Release

On September 24, 2024, MEDIROM Healthcare Technologies Inc. (the “Company”) is issuing a press release announcing its major Key Performance Indicators, or KPIs, updated for the month of August 2024.

The press release furnished in this report as Exhibit 99.1 shall not be deemed to be “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section, and shall not be deemed to be incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Exchange Act, as amended, except to the extent specifically provided in such a filing.

EXHIBIT INDEX

​

​

​

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

​